14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Cellectar Biosciences Stock Forecast

NASDAQ:CLRB BUY SELL

$0.36 (-0.30%)

Volume: 174.404k

Closed: May 23, 2022

Hollow Logo Score: -4.266

Cellectar Biosciences Stock Forecast

BUY SELL NASDAQ:CLRB
$0.36 (-0.30%)

Volume: 174.404k

Closed: May 23, 2022

Score Hollow Logo -4.266

Cellectar Biosciences Stock Forecast NASDAQ:CLRB

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2020-07-01 1288.89% Oppenheimer $5.00 Initiates Coverage On Outperform
2020-06-23 733.33% Maxim Group $3.00 Initiates Coverage On Buy
2020-01-21 2677.78% Roth Capital $10.00 Assumes Buy
2019-09-13 2955.56% Roth Capital $11.00 Initiates Coverage On Buy
2019-07-30 1566.67% Brookline Capital $6.00 Initiates Coverage On Buy

CLRB Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.34 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -14.75% during the next 3 months and, with a 90% probability hold a price between $0.29 and $0.60 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-25 $0.33 $0.52 $0.70
2022-05-26 $0.33 $0.52 $0.70
2022-05-27 $0.33 $0.51 $0.70
2022-05-31 $0.33 $0.51 $0.70
2022-06-01 $0.33 $0.51 $0.69
2022-06-02 $0.32 $0.51 $0.69
2022-06-03 $0.32 $0.51 $0.69
2022-06-06 $0.32 $0.50 $0.69
2022-06-07 $0.32 $0.50 $0.69
2022-06-08 $0.32 $0.50 $0.68
2022-06-09 $0.31 $0.50 $0.68
2022-06-10 $0.31 $0.50 $0.68
2022-06-13 $0.31 $0.49 $0.68
2022-06-14 $0.31 $0.49 $0.68
2022-06-15 $0.31 $0.49 $0.67
2022-06-16 $0.30 $0.49 $0.67
2022-06-17 $0.30 $0.49 $0.67
2022-06-21 $0.30 $0.48 $0.67
2022-06-22 $0.30 $0.48 $0.67
2022-06-23 $0.30 $0.48 $0.66
2022-06-24 $0.29 $0.48 $0.66
2022-06-27 $0.29 $0.48 $0.66
2022-06-28 $0.29 $0.47 $0.66
2022-06-29 $0.29 $0.47 $0.66
2022-06-30 $0.29 $0.47 $0.65
2022-07-01 $0.28 $0.47 $0.65
2022-07-05 $0.28 $0.47 $0.65
2022-07-06 $0.28 $0.46 $0.65
2022-07-07 $0.28 $0.46 $0.65
2022-07-08 $0.28 $0.46 $0.64

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, engages in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate and is currently being evaluated in a Phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT